MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersMicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesDiagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-AnalysisNeuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA DysregulationThe Possible Roles of the Dentate Granule Cell's Leptin and Other Ciliary Receptors in Alzheimer's NeuropathologyThe involvement of microRNAs in neurodegenerative diseasesPhysiological and pathological phosphorylation of tau by Cdk5Connecting the dots between tau dysfunction and neurodegenerationMicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.Cdk5 activity in the brain - multiple paths of regulation.Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia.MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's diseaseThe epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 proteinNeuronal cell cycle: the neuron itself and its circumstancesPlasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.microRNAs That Promote or Inhibit Memory Formation in Drosophila melanogaster.Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genesEvidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment.Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry.Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons.Regulation of Neuronal Cell Cycle and Apoptosis by MicroRNA 34aConserved miR-26b enhances ovarian granulosa cell apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease.MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseaseSystematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsySerum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.Nanoparticle-based detection of cancer-associated RNA.Protein phosphorylation in neurodegeneration: friend or foe?Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects.Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.Alzheimer's Disease and ncRNAs.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.
P2860
Q21129476-9DB703D9-1EF1-48A7-BDD9-5D70FF0D82DCQ26744819-DA6D5E44-51A8-445F-A83D-6D2A539F011AQ26768181-840546AD-E8DC-4FBA-88A7-FADC308D9890Q26770754-9FC13245-CB42-4191-8BAB-F5A8E835E9B1Q26799897-EF59C3B8-C154-4292-AFBB-AAC83C9767FDQ26858788-4A77201E-F32A-4641-8680-423F899ACFD1Q26860395-91A96B5D-88CE-4D8D-BCF2-07A973366C4BQ26996848-3C988C24-D22F-4852-A775-7955A1CA6D68Q30940333-41298932-07F2-4748-8B7E-71D464A3E971Q33687591-3E31A2CA-C03A-4A8C-AF70-1A3ADB30C3E1Q33916185-9AE579A1-7A2A-4FCB-8FC5-7F675DA7F830Q34324544-1B67B011-739F-4966-B606-C8924E657FA4Q34426210-0BE2C13E-74B6-4744-991D-72903D8F1D73Q34683454-3F12AE83-1014-4EC5-B9AF-EB2E53648E33Q35565056-166301EA-2322-42DD-8CA6-06E6679AC58DQ35795155-519B7B39-D6F3-4942-B0F6-4D3983D86DA7Q35821096-284C0B63-63ED-43A6-9CDD-8752B316BD51Q36166587-58A9B01D-3C2B-419E-98BA-BD83533ED126Q36249445-2CB5437C-216D-4E11-9B9E-D15D9327E949Q36288315-8C7FDD6B-18E6-449C-9A3E-0A0DF943975EQ36360931-32974AC8-ABF9-4CDA-94E9-7017698E72F2Q36433997-025479A2-7B3B-474F-B643-88250F9300FDQ36592055-B476A5FF-E15A-4530-8DC8-7282DFC4ED7AQ36681437-BD14C5A3-29DB-4B0E-B874-55E73E05F207Q36847079-09A5FBF3-B402-4D9D-AFBF-FBD519660795Q36939748-9DA90C94-AFA6-4578-AB3C-51D5C7E32D08Q37397124-66398D52-3903-4606-896C-ADCBADEB4A6AQ37535111-7A17FEE2-8688-4687-8ACC-09BF8D36467EQ37615645-D614E762-124D-4BDF-9E15-B6D694427EFDQ38201412-1B742775-91EB-4539-A458-61F98E65D96EQ38214594-46CB5FB6-3D4C-417B-8FE0-4B13F5BB82CFQ38224066-C823C42B-28EA-45EF-A5B3-B605D390AB14Q38367422-D0A3B43A-E94B-490C-94B6-91121FDEC03EQ38481462-CCDBA78B-4701-412A-B91C-8CF4D417F2B7Q38584755-0FD34B36-5EEA-4106-B5A4-85BD7F9EF525Q38612032-08E2DEAA-0924-404D-B2F6-63FC8CE3EF80Q38664298-64659F62-19DA-46BB-88E5-0F86D4EF8F51Q38681920-1E19047A-356D-4E15-898B-98923D845C50Q38836004-8AB83B1B-9543-4235-9773-6C00AC7C8F5DQ38927615-B1F9D873-7008-4BDA-B885-668560D31412
P2860
MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MiR-26b, upregulated in Alzhei ...... optosis in postmitotic neurons
@en
MiR-26b, upregulated in Alzhei ...... ptosis in postmitotic neurons.
@nl
type
label
MiR-26b, upregulated in Alzhei ...... optosis in postmitotic neurons
@en
MiR-26b, upregulated in Alzhei ...... ptosis in postmitotic neurons.
@nl
prefLabel
MiR-26b, upregulated in Alzhei ...... optosis in postmitotic neurons
@en
MiR-26b, upregulated in Alzhei ...... ptosis in postmitotic neurons.
@nl
P2860
P921
P1476
MiR-26b, upregulated in Alzhei ...... optosis in postmitotic neurons
@en
P2093
Anna M Krichevsky
Dawn M Kochanek
P2860
P304
14645-14659
P356
10.1523/JNEUROSCI.1327-13.2013
P407
P577
2013-09-01T00:00:00Z